Title
Report regarding consideration of a Design Review Modification, Development Agreement Amendment and Addendum to the Mitigated Negative Declaration for the previously approved Research & Development project at 233 East Grand Avenue/328-340 Roebling Road in the Business Technology Park (BTP) Zone District. (Billy Gross, Senior Planner)
label
RECOMMENDATION
Recommendation
Staff recommends that the City Council conduct a public hearing, follow the recommendation of the Planning Commission, and take the following actions:
1) Approve a resolution making findings and determining that the 233 East Grand Avenue/328-340 Roebling Project is fully within the scope of environmental analysis in the previously certified 2012 Mitigated Negative Declaration and that the 2020 Addendum is the appropriate environmental document for the Project;
2) Introduce an Ordinance approving the First Amendment to the Development Agreement between Bayside Area Development, LLC, and the City, and waive further reading; and,
3) Adopt a Resolution approving the Design Review Modification to allow for an increase in Floor Area Ratio (FAR) from 0.81 to 1.0 for the project at 233 East Grand Ave / 328-340 Roebling Road in the Business and Technology Park (BTP) Zoning District, subject to the attached Draft Conditions of Approval.
Body
BACKGROUND
Overview
The project site is located at the corner of Roebling Road and East Grand Avenue, and was acquired by Healthpeak Properties (formerly called HCP Life Sciences) for development into a small office/R&D campus. The 2.97-acre site includes three separate parcels, with each parcel containing one existing office/warehouse building.
On November 12, 2012, the City Council approved entitlements to allow demolition of the existing buildings and construction of a biotechnology campus with two 2-story office/R&D buildings totaling about 105,536 sq. ft., with a combination of at-grade and subterranean parking (Entitled Project). Specific entitle...
Click here for full text